Business Money

India’s Aurobindo Pharma receives USFDA approval

Aurobindo Pharma Limited has received tentative approval from the US Food & Drug Administration to make and sell Venlafaxine Hydrochloride Extended-release

These capsules are indicated for the treatment of major depressive disorder (MDD) and falls under the Neurological (CNS) therapeutic category. The product has a market size of US$ 2.4 billion (in 2010) according to IMS.

The tentatively approved ANDA  is currently under litigation in the United States District Court [Wyeth LLC v. Aurobindo Pharma Limited]. The product will be launched after the litigation settlement.

Headquartered in India’s Hyderabad, Aurobindo Pharma Limited (www.aurobindo.com) makes generic pharmaceuticals and active pharmaceutical ingredients.

You Might Also Like

No Comments

Leave a Reply